Search

Displaying results 289 to 297 of 1175.

Pages

Prof. Dr. Yannic Bartsch

Prof Dr Yannic Bartsch Head of Research Group +49 511 220027-1049 E-Mail Yannic Bartsch is the head of the Junior Research Group and W1 Professor for "Anti-viral Antibody-omics" at TWINCORE, a joint venture of the Helmholtz…

Read more
Elektronenmikroskopische Aufnahme von Viruspartikeln des Grippeerregers Influenza.
News
Universal Flu Vaccine Candidate Protects Against Infection in Animal Models
Annual flu vaccines protect against severe infection, but they vary in efficacy and may not match the most virulent strains of the season. The reality of a universal flu vaccine, which would protect people from all...
10.09.2024
Dr. Peter Sullivan in the lab.
Interview
MyxoTech takes off
A key focus at the Helmholtz Centre for Infection Research (HZI) and its sites like the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is translating research findings into medical and pharmaceutical...
29.08.2024
Group photo 4 scientists with a large cheque
News
IBT Lower Saxony: Incubator for Biomedical Innovation awards 1.6 million euros
Yesterday, the lighthouse project of the state of Lower Saxony reached its latest milestone: At the second portfolio conference of the Institute for Biomedical Translation (IBT) Lower Saxony, a high-caliber jury...
28.08.2024
Interview
"The WHO reacted in time"
The current outbreak of the Mpox virus originated in Central Africa. A first case has now been discovered in Europe. The WHO has declared the highest alert level. In an interview with Helmholtz, Fabian Leendertz,...
23.08.2024
Marco Galardini (left) and Maureen Obara in the lab.
News
More than the sum of the parts
Certain changes in the genetic material of pathogens can alter their ability to infect human cells or protect them better from defense by the immune system. Researchers were able to observe this effect particularly...
23.08.2024

Tuberculosis – a silent pandemic

Read more
3D illustration of the cytomegalovirus
News
New vector vaccine against COVID-19 provides long-term protection
The protective effect of established COVID-19 vaccines is initially very robust, but wanes relatively quickly. This limitation imposes a need for periodic booster shots, which drives vaccine hesitation. In contrast, an...
20.08.2024

Translation – bridging the gap between lab bench and clinic

Read more